STAAR Surgical Stock Drops Amid Q2 Results | Business and Finance News

STAAR Surgical’s stock took an eight percent hit after a disappointing Q2 earnings report, closing at $24.15 — but don’t panic: this dip fits a pattern of wild swings, with over thirty five-percent moves in the past year. While the stock is still up 2% year-to-date, it’s lagging far behind its May peak and would’ve lost value if you’d invested $1,000 five years ago. Investors are watching closely as the company navigates tough market scrutiny — and while volatility can be nerve-wracking, these dips might just be buying opportunities for savvy traders. Listen in comfort:Get a discount on a Soli Pillow: http://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/feb15e1b53ef2f1d